<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04995289</url>
  </required_header>
  <id_info>
    <org_study_id>MohammedVIUH</org_study_id>
    <nct_id>NCT04995289</nct_id>
  </id_info>
  <brief_title>Prone Position During ECMO in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hypoxaemic Patient</brief_title>
  <official_title>Prone Position During ECMO in Covid Hypoxaemic Patient :A PROCESS-compliant Case Series From the Eastern Morocco</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mohammed VI University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mohammed VI University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction:&#xD;
&#xD;
      The main manifestation of COVID-19 pneumonia is acute respiratory distress syndrome (ARDS),&#xD;
      which in some cases can be more severe than intubation, extracorporeal membrane venous&#xD;
      oxygenation (VV-ECMO) to ensure hematosis. Despite support from VV-ECMO, some patients may&#xD;
      remain hypoxemic. One possible therapeutic procedure for these patients is the application of&#xD;
      the prone position.&#xD;
&#xD;
      Objective:&#xD;
&#xD;
      The main aim of this study was to investigate the modification of the PaO2/FiO2 ratio, the&#xD;
      compliance of the respiratory system in VV-ECMO with refractory hypoxemia. The secondary&#xD;
      objective was to evaluate the safety and feasibility of the inclined position for ECMO.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      the investigators reviewed the electronic records and lists of all 23 COVID-19 patients. were&#xD;
      placed for the first time in PP with an average duration of 16 h . patient characteristics,&#xD;
      pre-ECMO characteristics, ventilator/ECMO settings, and changes in ventilator/ECMO settings&#xD;
      and blood gas analysis before and after PP.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of the current study was to investigate the change in PaO2/FiO2 ratio, the&#xD;
      compliance of the respiratory system in VV-ECMO patients with persistent hypoxemia.&#xD;
      Measurements were taken before PP, 1 h after the start of the PP, at the end of the PP cycle.&#xD;
&#xD;
      The secondary objective of this study was to assess the safety and feasibility of emergency&#xD;
      positioning for patients with severe ARDS during ECMO treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Actual">January 30, 2021</completion_date>
  <primary_completion_date type="Actual">January 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>amelioration of PaO2/FiO2</measure>
    <time_frame>through study completion, an average of 1 yea</time_frame>
    <description>the investigators recoordeed Blood gas analysis before and after Prone position</description>
  </primary_outcome>
  <enrollment type="Actual">23</enrollment>
  <condition>SARS CoV 2 Infection</condition>
  <condition>Hypoxemic Respiratory Failure</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prone position on ECMO patient</intervention_name>
    <description>blood gas analysis before and after PP</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        23 patients admitted to the intensive care unit of different genders and ethnicities were&#xD;
        included.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of SARS COV 2 infection complicated by ARDS, and needed a VV ECMO.&#xD;
&#xD;
          -  patient who presented refractory hypoxemia during VV ECMO.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient who has received ECMO V-A or ECMO VV for reasons other than ARDS.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>younes Oujidi</name>
      <address>
        <city>Berkane</city>
        <zip>9999</zip>
        <country>Morocco</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Morocco</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 28, 2021</study_first_submitted>
  <study_first_submitted_qc>July 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mohammed VI University Hospital</investigator_affiliation>
    <investigator_full_name>Younes Oujidi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>ECMO</keyword>
  <keyword>ARDS</keyword>
  <keyword>Prone position</keyword>
  <keyword>COVID</keyword>
  <keyword>compliance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

